Certain aspects of drug binding to nonplasma proteins as illustrated by studies with cyclizine, chlorcyclizine, and polymyxin B.
D000596:Amino Acids / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology; D000818:Animals; D002794:Choline / Q000494:pharmacology; D004396:Coloring Agents; D003501:Cyclizine / Q000378:metabolism*; D003640:Dealkylation; D004285:Dogs; D005260:Female; D005978:Glutathione / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D010879:Piperazines / Q000378:metabolism*; D011113:Polymyxins / Q000378:metabolism*; D011485:Protein Binding; D051381:Rats; D013045:Species Specificity; D013154:Spleen / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000596:Amino Acids; D000613:Aminobutyrates; D004396:Coloring Agents; D006634:Histamine H1 Antagonists; D010879:Piperazines; D011113:Polymyxins; D014316:Tritium; D005978:Glutathione; D002794:Choline; D003501:Cyclizine